NCT02719951View on ClinicalTrials.gov

Glutaminergic Transmission in Autism : Molecular Imaging Exploration

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

November 15, 2018

Study Completion Date

May 31, 2019

Conditions
AutismFragile-X Syndrome (FXS)Healthy Volunteers
Interventions
DRUG

[18F]FPEB PET imaging

PET exam

OTHER

Biological samples

blood sample and urine sample

OTHER

MRI

MRI exam

Trial Locations (1)

37044

CHU Tours, Tours

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT02719951 - Glutaminergic Transmission in Autism : Molecular Imaging Exploration | Biotech Hunter | Biotech Hunter